Kunming, China

Yonggang Yao


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yonggang Yao: Innovator in Neurodegenerative Disease Treatment

Introduction

Yonggang Yao is a prominent inventor based in Kunming, China. He has made significant contributions to the field of medicine, particularly in the treatment and prevention of neurodegenerative diseases. His innovative approach has led to the development of a unique pharmaceutical composition that holds promise for patients suffering from these debilitating conditions.

Latest Patents

Yonggang Yao holds a patent for the "Use of Gemfibrozil and derivative thereof for treatment and/or prevention of neurodegenerative disease." This patent outlines the use of Gemfibrozil, along with its pharmaceutically acceptable salts, esters, or stereoisomers, in the preparation of a medicament aimed at treating or preventing neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. The patent also details a pharmaceutical composition that includes Gemfibrozil and one or more pharmaceutically acceptable carriers.

Career Highlights

Yonggang Yao is affiliated with the Chinese Academy of Sciences, where he has been instrumental in advancing research in neurodegenerative diseases. His work has not only contributed to scientific knowledge but also has the potential to improve the quality of life for many individuals affected by these conditions.

Collaborations

Yao has collaborated with notable colleagues, including Rongcan Luo and Guiyu Li. These partnerships have fostered a collaborative environment that enhances the research and development of innovative treatments.

Conclusion

Yonggang Yao's contributions to the field of neurodegenerative disease treatment through his patent on Gemfibrozil exemplify the impact of innovative thinking in medicine. His work continues to inspire advancements that may lead to effective therapies for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…